SEC EDGAR: material events, stakes, listings, share offerings, annual and quarterly reports.
Tuesday 18 August 2026
1,263 records- 8-K
Netcapital Inc. says earlier financial statements can no longer be relied on
Form 8-K, items 4.01, 4.02. Also changed its auditor.
- 8-K
CID Holdco, Inc. reports debt accelerated by a triggering event
Form 8-K, items 2.04, 3.01. Also received a delisting or listing-standard notice.
- 8-K
Offerpad Solutions Inc. received a delisting or listing-standard notice
Form 8-K, items 3.01, 7.01. Also made a Regulation FD disclosure.
- 8-K
Agriculture & Natural Solutions Acquisition Corp received a delisting or listing-standard notice
Form 8-K, item 3.01.
- 8-K
Liminatus Pharma, Inc. received a delisting or listing-standard notice
Form 8-K, items 3.01, 3.03. Also changed shareholders’ rights.
- 8-K
Firsthand Technology Value Fund, Inc. received a delisting or listing-standard notice
Form 8-K, items 3.01, 5.02, 8.01. Also reports a director or officer change; reported other events.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Advasa Holdings, Inc. and Akimoto Tatsuya.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming BlossomHill Therapeutics, Inc. and Orbimed Advisors LLC.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Conexeu Sciences Inc. and Sharpe Jeffrey Nathan.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Advasa Holdings, Inc. and Kosugi Asamitsu.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Paine Schwartz Food Chain Fund V GP, Ltd. and Suja Life, Inc.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Jones William Allan and Katapult Holdings, Inc.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Braveheart Bio, Inc. and Orbimed Advisors LLC.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming KMJ Group Holdings, LLC and Katapult Holdings, Inc.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming BasePoint Group Inc. and Katapult Holdings, Inc.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Digital Currency Group, Inc. and HeartSciences Inc.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Cywinski Friedrich Edwin and SunScout Holding Ltd.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Cywinski Marc and SunScout Holding Ltd.
- 8-K
Arxis, Inc. completed an acquisition or disposal
Form 8-K, items 2.01, 3.02. Also sold shares without registration.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Grain Bud Holding Ltd and KE Holdings Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Prescott General Partners LLC and World Acceptance Corp.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Enhanced Group Inc. and Martin Maximilian.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Fresenius Medical Care Holdings Inc /NY/ and Humacyte, Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Better Home & Finance Holding Co and Garg Vishal.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Ensysce Biosciences, Inc. and Gower Bob G.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming JBS USA Holding Lux S.a R.L. and Pilgrims Pride Corp.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming NYLI CBRE Global Infrastructure Megatrends Term Fund and Saba Capital Management, L.P.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming 5AM Partners VII, LLC and Skye Bioscience, Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Cerebras Systems Inc. and Eclipse Continuity GP I, LLC.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Alco Investment Co and Banzai International, Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Birkenstock Holding plc and CB Beteiligungs GmbH & Co. KG.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Ren Yinan and YY Group Holding Ltd.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming AMG BBH Asset-Backed Credit Fund, LLC and Brown Brothers Harriman & Co.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Baihui Partners L.P. and KE Holdings Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming TPG GP A, LLC and TPG Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Cywinski Marc and SunScout Holding Ltd.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Catalyst4, Inc. and MapLight Therapeutics, Inc.
- 8-K
Wec Energy Group, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Positron Corp entered a material agreement
Form 8-K, item 1.01.
- 8-K
Range Impact, Inc. entered a material agreement
Form 8-K, items 1.01, 3.02. Also sold shares without registration.
- 8-K
Treasure Global Inc entered a material agreement
Form 8-K, items 1.01, 1.02. Also ended a material agreement.
- 8-K
Super League Enterprise, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
XCF Global, Inc. entered a material agreement
Form 8-K, items 1.01, 3.02. Also sold shares without registration.
- 8-K
Newbury Street II Acquisition Corp entered a material agreement
Form 8-K, item 1.01.
- 8-K
TruGolf Holdings, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Super League Enterprise, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Universal Technical Institute Inc entered a material agreement
Form 8-K, items 1.01, 2.03, 7.01. Also took on a new financial obligation; made a Regulation FD disclosure.
- 8-K
Zoned Properties, Inc. entered a material agreement
Form 8-K, items 1.01, 8.01. Also reported other events.
- 8-K
Rexford Industrial Realty, Inc. entered a material agreement
Form 8-K, items 1.01, 7.01. Also made a Regulation FD disclosure.
- 8-K
TScan Therapeutics, Inc. ended a material agreement
Form 8-K, item 1.02.
- 8-K
WaterBridge Infrastructure LLC entered a material agreement
Form 8-K, items 1.01, 2.03, 8.01. Also took on a new financial obligation; reported other events.
- 8-K
Singularity Future Technology Ltd. entered a material agreement
Form 8-K, items 1.01, 3.02. Also sold shares without registration.
- 8-K
ReposiTrak, Inc. entered a material agreement
Form 8-K, items 1.01, 5.02. Also reports a director or officer change.
- 8-K
NextBoat Inc. entered a material agreement
Form 8-K, items 1.01, 2.03, 3.02. Also took on a new financial obligation; sold shares without registration.
- 8-K
Sezzle Inc. entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
XTI Aerospace, Inc. entered a material agreement
Form 8-K, items 1.01, 5.02. Also reports a director or officer change.
- 8-K
Synchrony Card Funding, LLC entered a material agreement
Form 8-K, items 1.01, 6.05, 8.01. Also reported other events.
- 8-K
Wrap Technologies, Inc. entered a material agreement
Form 8-K, items 1.01, 8.01. Also reported other events.
- 8-K
Sadot Group Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Baxter International Inc entered a material agreement
Form 8-K, items 1.01, 8.01. Also reported other events.
- 8-K
HeartSciences Inc. entered a material agreement
Form 8-K, items 1.01, 3.02. Also sold shares without registration.
- 8-K
La Rosa Holdings Corp. entered a material agreement
Form 8-K, items 1.01, 3.02. Also sold shares without registration.
- 8-K
Cco Holdings LLC entered a material agreement
Form 8-K, item 1.01.
- 8-K
Biomarin Pharmaceutical Inc entered a material agreement
Form 8-K, items 1.01, 7.01. Also made a Regulation FD disclosure.
- 8-K
Blue Owl Capital Inc. entered a material agreement
Form 8-K, items 1.01, 2.03, 8.01. Also took on a new financial obligation; reported other events.
- 8-K
Mitesco, Inc. entered a material agreement
Form 8-K, items 1.01, 3.02, 8.01. Also sold shares without registration; reported other events.
- 8-K
AB Private Credit Investors Corp entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
Apollo Debt Solutions BDC entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
ExlService Holdings, Inc. entered a material agreement
Form 8-K, items 1.01, 1.02, 2.03, 7.01. Also ended a material agreement; took on a new financial obligation; made a Regulation FD disclosure.
- 8-K
Cypherpunk Technologies Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Change Agents Corporation. entered a material agreement
Form 8-K, items 1.01, 2.03, 3.02. Also took on a new financial obligation; sold shares without registration.
- 8-K
Diodes Inc /Del/ entered a material agreement
Form 8-K, item 1.01.
- 8-K
Datavault AI Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Barings Private Credit Corp entered a material agreement
Form 8-K, item 1.01.
- 8-K
Agenus Inc entered a material agreement
Form 8-K, items 1.01, 2.03, 3.02. Also took on a new financial obligation; sold shares without registration.
- 8-K
Evolution Petroleum Corp entered a material agreement
Form 8-K, items 1.01, 7.01. Also made a Regulation FD disclosure.
- 8-K
Intrusion Inc entered a material agreement
Form 8-K, items 1.01, 3.02. Also sold shares without registration.
- 8-K
Acorn Energy, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Cco Holdings Capital Corp entered a material agreement
Form 8-K, item 1.01.
- 8-K
Charter Communications, Inc. /MO/ entered a material agreement
Form 8-K, item 1.01.
- 8-K
Curbline Properties Corp. ended a material agreement
Form 8-K, items 1.02, 3.03. Also changed shareholders’ rights.
- 8-K
Idt Corp entered a material agreement
Form 8-K, item 1.01.
- 8-K
Martin Marietta Materials Inc entered a material agreement
Form 8-K, items 1.01, 1.02, 2.03. Also ended a material agreement; took on a new financial obligation.
- 8-K
Transglobal Management Group, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
York Water Co reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Tonix Pharmaceuticals Holding Corp. reports a director or officer change
Form 8-K, items 5.02, 8.01. Also reported other events.
- 8-K
Oglethorpe Power Corp reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Texas Ventures Acquisition III Corp reports a director or officer change
Form 8-K, item 5.02.
- 8-K
nVent Electric plc reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Privia Health Group, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Xylem Inc. reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Rhinebeck Bancorp, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Nano Dimension Ltd. reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Franklin Financial Services Corp /PA/ reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Catalyst Bancorp, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Columbus Mckinnon Corp reports a director or officer change
Form 8-K, items 5.02, 5.07. Also reported shareholder vote results.
- 8-K
Copart Inc reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
ChronoScale Holdings Corp reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Duos Technologies Group, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
GE HealthCare Technologies Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Kennametal Inc reports a director or officer change
Form 8-K, items 5.02, 8.01. Also reported other events.
- 8-K
Legacy Housing Corp reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Legence Corp. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Amaze Holdings, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Centrus Energy Corp reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Brighthouse Financial, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
GoPro, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Cocrystal Pharma, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Blue Water Acquisition Corp. IV reports a director or officer change
Form 8-K, item 5.02.
- 8-K
First Industrial Realty Trust Inc reports a director or officer change
Form 8-K, item 5.02.
- 8-K
First Industrial LP reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Halozyme Therapeutics, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Foxx Development Holdings Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Levi Strauss & Co reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Federal Home Loan Bank of Pittsburgh took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of Des Moines took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of Atlanta took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of Boston took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of Chicago took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of Cincinnati took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of Dallas took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of Indianapolis took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of New York took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of San Francisco took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Federal Home Loan Bank of Topeka took on a new financial obligation
Form 8-K, item 2.03.
- 8-K
Launch Two Acquisition Corp. took on a new financial obligation
Form 8-K, items 2.03, 8.01. Also reported other events.
- Offering
Freenome, Inc. filed to register new shares
Form S-1, registration statement.
- 8-K
Turn Therapeutics Inc. sold shares without registration
Form 8-K, item 3.02.
- 8-K
Trio Petroleum Corp changed shareholders’ rights
Form 8-K, items 3.03, 5.03, 7.01. Also amended its articles or bylaws; made a Regulation FD disclosure.
- 8-K
Archer Aviation Inc. sold shares without registration
Form 8-K, items 3.02, 8.01. Also reported other events.
- Offering
Karman Line Acquisition Corp. published a final prospectus
Form 424B4, prospectus for a priced offering.
- 8-K
Sypris Solutions Inc published results
Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
OneMeta Inc. published results
Form 8-K, item 2.02.
- 8-K
OMNIQ Corp. published results
Form 8-K, item 2.02.
- 8-K
Toll Brothers, Inc. published results
Form 8-K, item 2.02.
- 8-K
Mercury Systems Inc published results
Form 8-K, item 2.02.
- 8-K
Asiafin Holdings Corp. published results
Form 8-K, item 2.02.
- 8-K
Axil Brands, Inc. published results
Form 8-K, item 2.02.
- 8-K
Home Depot, Inc. published results
Form 8-K, item 2.02.
- 8-K
374Water Inc. published results
Form 8-K, item 2.02.
- 8-K
Elauwit Connection, Inc. published results
Form 8-K, item 2.02.
- 8-K
Flash Sports & Media Holdings, Inc. published results
Form 8-K, item 2.02.
- 8-K
Jack Henry & Associates Inc published results
Form 8-K, item 2.02.
- 8-K
La-Z-Boy Inc published results
Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Iridex Corp published results
Form 8-K, item 2.02.
- 8-K
Keysight Technologies, Inc. published results
Form 8-K, item 2.02.
- 8-K
DataMeds AI, Inc. published results
Form 8-K, item 2.02.
- 8-K
Beyond Air, Inc. published results
Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Bridgeline Digital, Inc. published results
Form 8-K, item 2.02.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Processa Pharmaceuticals, Inc. and Soleus Capital Master Fund, L.P.
- Insider trades
1,012 insider-trade forms filed by directors and major holders
Shown as a count until Loro reads the transactions inside them: who bought or sold, how many shares, at what price. Most filings: Kennametal Inc (16), EnerSys (14), FS Bancorp, Inc. (14), Paylocity Holding Corp (14), Meta Platforms, Inc. (12), First Financial Bankshares Inc (11).
SEC Form 4
Showing the 150 most material of 251.
Monday 17 August 2026
1,009 records- 8-K
Nocera, Inc. says earlier financial statements can no longer be relied on
Form 8-K, item 4.02.
- 8-K
Talkspace, Inc. received a delisting or listing-standard notice
Form 8-K, items 2.01, 3.01, 3.03, 5.01, 5.02, 5.03. Also reports a change in control; completed an acquisition or disposal; reports a director or officer change; changed shareholders’ rights; amended its articles or bylaws.
- 8-K
Nexalin Technology, Inc. received a delisting or listing-standard notice
Form 8-K, item 3.01.
- 8-K
Cloudastructure, Inc. received a delisting or listing-standard notice
Form 8-K, items 2.02, 3.01. Also published results.
- 8-K
Helix Acquisition Corp. III received a delisting or listing-standard notice
Form 8-K, item 3.01.
- 8-K
Protopia Global Holdings Inc. changed its auditor
Form 8-K, item 4.01.
- 8-K
Resmed Inc changed its auditor
Form 8-K, items 4.01, 5.02, 7.01. Also reports a director or officer change; made a Regulation FD disclosure.
- 8-K
CIFC Direct Lending Evergreen Fund changed its auditor
Form 8-K, item 4.01.
- 8-K
Limoneira CO reports a material impairment
Form 8-K, items 1.01, 2.06, 8.01. Also entered a material agreement; reported other events.
- Delisting
New York Stock Exchange LLC filed to remove Erp Operating Ltd Partnership from listing
Form 25-NSE, notice of removal from listing and registration.
- Delisting
New York Stock Exchange LLC filed to remove Avalonbay Communities Inc from listing
Form 25-NSE, notice of removal from listing and registration.
- Delisting
Nasdaq Stock Market LLC filed to remove Talkspace, Inc. from listing
Form 25-NSE, notice of removal from listing and registration.
- Delisting
Nyse Arca, Inc. filed to remove Ishares Trust from listing
Form 25-NSE, notice of removal from listing and registration.
- Delisting
Nyse Arca, Inc. filed to remove iShares U.S. ETF Trust from listing
Form 25-NSE, notice of removal from listing and registration.
- Delisting
Nasdaq Stock Market LLC filed to remove Dermata Therapeutics, Inc. from listing
Form 25-NSE, notice of removal from listing and registration.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Alumis Inc. and Foresite Capital Fund VI LP.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Pinnacle Acquisition Corp and Rechtschaffen Andrew.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Femasys Inc and Nantahala Capital Partners Limited Partnership.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Foresite Capital Fund VI LP and Latigo Biotherapeutics, Inc.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Hudson Steven Kenneth and Pinnacle Acquisition Corp.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming PAC Sponsor, LLC and Pinnacle Acquisition Corp.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming HWH International Inc. and Liu Ming Hui.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Jewett Cameron Trading Co Ltd and Kotarba Partners Fund I, LP.
- 8-K
Erp Operating Ltd Partnership completed an acquisition or disposal
Form 8-K, item 2.01.
- 8-K
Avalonbay Communities Inc completed an acquisition or disposal
Form 8-K, item 2.01.
- 8-K
Braemar Hotels & Resorts Inc. completed an acquisition or disposal
Form 8-K, item 2.01.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming SR One Capital Management, LLC and Zenas BioPharma, Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Hudson Executive Capital LP and Talkspace, Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Artikkhodjaev Jakhongir Abidovich and StageWise Strategies Corp.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Dreamland Ltd and Seto Wai Yue.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Butterfly Network, Inc. and Glenview Capital Management, LLC.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming AMG BBH Asset-Backed Credit Fund, LLC and Brown Brothers Harriman & Co.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Better Home & Finance Holding Co and Garg Vishal.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming BridgeBio Pharma, Inc. and KKR Genetic Disorder L.P.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Maplebear Inc. and SC US (TTGP), Ltd.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Diana Shipping Inc. and Genco Shipping & Trading Ltd.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Legorreta Pablo G. and Royalty Pharma plc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Qumra Capital II, L.P. and Talkspace, Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Apollomics Inc. and Chen Hung-Wen.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Activant Ventures Advisors III, LLC and Better Home & Finance Holding Co.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Centerbridge Associates III, L.P. and GoHealth, Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Battalion Oil Corp and Brookfield Oaktree Holdings, LLC.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming 8 Rivers Capital, LLC and Net Power Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Butterfly Network, Inc. and Rothberg Jonathan M.
- 8-K
Non Invasive Monitoring Systems Inc /FL/ entered a material agreement
Form 8-K, item 1.01.
- 8-K
Nvidia Corp entered a material agreement
Form 8-K, items 1.01, 2.03, 7.01. Also took on a new financial obligation; made a Regulation FD disclosure.
- 8-K
Teradata Corp /DE/ entered a material agreement
Form 8-K, item 1.01.
- 8-K
Starz Entertainment Corp /CN/ entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
WhiteFiber, Inc. entered a material agreement
Form 8-K, items 1.01, 7.01. Also made a Regulation FD disclosure.
- 8-K
Pilgrims Pride Corp entered a material agreement
Form 8-K, items 1.01, 7.01. Also made a Regulation FD disclosure.
- 8-K
Valion Bio, Inc. entered a material agreement
Form 8-K, items 1.01, 3.02, 5.02, 5.07, 8.01. Also reports a director or officer change; sold shares without registration; reported shareholder vote results; reported other events.
- 8-K
Narragansett Bancorp, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Phoenix Energy One, LLC entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
TTM Technologies Inc entered a material agreement
Form 8-K, item 1.01.
- 8-K
Securetech Innovations, Inc. entered a material agreement
Form 8-K, items 1.01, 1.02, 3.02. Also ended a material agreement; sold shares without registration.
- 8-K
Unifi Inc entered a material agreement
Form 8-K, items 1.01, 7.01. Also made a Regulation FD disclosure.
- 8-K
Prairie Operating Co. entered a material agreement
Form 8-K, items 1.01, 2.03, 3.03. Also took on a new financial obligation; changed shareholders’ rights.
- 8-K
Ugi Corp /PA/ entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
Sharing Economy International Inc. entered a material agreement
Form 8-K, items 1.01, 3.02, 3.03. Also sold shares without registration; changed shareholders’ rights.
- 8-K
Singularity Future Technology Ltd. entered a material agreement
Form 8-K, items 1.01, 3.02. Also sold shares without registration.
- 8-K
Galaxy Gaming, Inc. entered a material agreement
Form 8-K, items 1.01, 7.01. Also made a Regulation FD disclosure.
- 8-K
Erp Operating Ltd Partnership entered a material agreement
Form 8-K, item 1.01.
- 8-K
Fabrinet entered a material agreement
Form 8-K, items 1.01, 2.02, 2.03, 5.02. Also reports a director or officer change; took on a new financial obligation; published results.
- 8-K
Fulcrum Therapeutics, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Advanced Micro Devices Inc entered a material agreement
Form 8-K, item 1.01.
- 8-K
HomeTrust Bancshares, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Mastec Inc entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
Coherus Oncology, Inc. entered a material agreement
Form 8-K, items 1.01, 1.02, 2.03. Also ended a material agreement; took on a new financial obligation.
- 8-K
Madison Air Solutions Corp entered a material agreement
Form 8-K, item 1.01.
- 8-K
Nextnrg, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Abundia Global Impact Group, Inc. entered a material agreement
Form 8-K, items 1.01, 2.03, 8.01. Also took on a new financial obligation; reported other events.
- 8-K
AdvanSix Inc. entered a material agreement
Form 8-K, items 1.01, 1.02, 2.03. Also ended a material agreement; took on a new financial obligation.
- 8-K
BridgeBio Pharma, Inc. entered a material agreement
Form 8-K, items 1.01, 8.01. Also reported other events.
- 8-K
Dare Bioscience, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Fastly, Inc. entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
FingerMotion, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Future Vision II Acquisition Corp. entered a material agreement
Form 8-K, items 1.01, 2.03, 3.02, 8.01. Also took on a new financial obligation; sold shares without registration; reported other events.
- 8-K
Microvision, Inc. entered a material agreement
Form 8-K, items 1.01, 8.01. Also reported other events.
- 8-K
Dermata Therapeutics, Inc. entered a material agreement
Form 8-K, items 1.01, 3.02. Also sold shares without registration.
- 8-K
DocGo Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Avax One Technology Ltd. entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
Alaska Silver Corp. entered a material agreement
Form 8-K, items 1.01, 3.02. Also sold shares without registration.
- 8-K
Intest Corp entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
Blue Ridge Bankshares, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Ulta Beauty, Inc. reports a director or officer change
Form 8-K, items 5.02, 8.01. Also reported other events.
- 8-K
Neuronetics, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Rocket Companies, Inc. reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Vista Gold Corp reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
TON Strategy Co reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Profound Medical Corp. reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Park Aerospace Corp reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Wendy's Co reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Scansource, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
LiveRamp Holdings, Inc. reports a director or officer change
Form 8-K, items 5.02, 5.07. Also reported shareholder vote results.
- 8-K
L3harris Technologies, Inc. /DE/ reports a director or officer change
Form 8-K, items 5.02, 7.01, 8.01. Also made a Regulation FD disclosure; reported other events.
- 8-K
Global Crossing Airlines Group Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Idex Corp /DE/ reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Ispire Technology Inc. reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Kulicke & Soffa Industries Inc reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
CVS HEALTH Corp reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Aon plc reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Bakkt, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Edible Garden AG Inc reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Enovix Corp reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Maze Therapeutics, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
NNN REIT, Inc. reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Centene Corp reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
BigBear.ai Holdings, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
D-Wave Quantum Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Horizon Bancorp Inc /In/ reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Kaiser Aluminum Corp reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Universal Health Services Inc took on a new financial obligation
Form 8-K, items 2.03, 8.01. Also reported other events.
- 8-K
Mosaic Co took on a new financial obligation
Form 8-K, items 2.03, 8.01. Also reported other events.
- Offering
Andersen Group Inc. filed to register new shares
Form S-1, registration statement.
- Offering
Alliance Laundry Holdings Inc. filed to register new shares
Form S-1, registration statement.
- Offering
VS Trust filed to register new shares
Form S-1, registration statement.
- 8-K
Curanex Pharmaceuticals Inc changed shareholders’ rights
Form 8-K, items 3.03, 5.03. Also amended its articles or bylaws.
- 8-K
Leatt Corp changed shareholders’ rights
Form 8-K, items 3.03, 5.03, 5.07. Also reported shareholder vote results; amended its articles or bylaws.
- Offering
Abvc Biopharma, Inc. published a final prospectus
Form 424B4, prospectus for a priced offering.
- Offering
Abvc Biopharma, Inc. published a final prospectus
Form 424B4, prospectus for a priced offering.
- Offering
Abvc Biopharma, Inc. published a final prospectus
Form 424B4, prospectus for a priced offering.
- Offering
Abvc Biopharma, Inc. published a final prospectus
Form 424B4, prospectus for a priced offering.
- 8-K
QDM International Inc. published results
Form 8-K, item 2.02.
- 8-K
Vuzix Corp published results
Form 8-K, item 2.02.
- 8-K
Prairie Operating Co. published results
Form 8-K, item 2.02.
- 8-K
NRX Pharmaceuticals, Inc. published results
Form 8-K, item 2.02.
- 8-K
Permianville Royalty Trust published results
Form 8-K, item 2.02.
- 8-K
Tiaa Real Estate Account published results
Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
United States Antimony Corp published results
Form 8-K, item 2.02.
- 8-K
Pioneer Power Solutions, Inc. published results
Form 8-K, item 2.02.
- 8-K
Perfect Moment Ltd. published results
Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
QumulusAI, Inc. published results
Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Widepoint Corp published results
Form 8-K, item 2.02.
- 8-K
Nuo Therapeutics, Inc. published results
Form 8-K, item 2.02.
- 8-K
ENDRA Life Sciences Inc. published results
Form 8-K, item 2.02.
- 8-K
20/20 Biolabs, Inc. published results
Form 8-K, item 2.02.
- 8-K
Amass Brands published results
Form 8-K, item 2.02.
- 8-K
Generation Income Properties, Inc. published results
Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
InspireMD, Inc. published results
Form 8-K, item 2.02.
- 8-K
Adial Pharmaceuticals, Inc. published results
Form 8-K, item 2.02.
- 8-K
Empire Petroleum Corp published results
Form 8-K, item 2.02.
- 8-K
INVO Fertility, Inc. published results
Form 8-K, item 2.02.
- 8-K
Nexgel, Inc. published results
Form 8-K, item 2.02.
- 8-K
AMC Robotics Corp published results
Form 8-K, item 2.02.
- 8-K
Blue Dolphin Energy Co published results
Form 8-K, item 2.02.
- 8-K
HIVE Digital Technologies Ltd. published results
Form 8-K, item 2.02.
- 8-K
Flexsteel Industries Inc published results
Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Functional Brands Inc. published results
Form 8-K, item 2.02.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Groupon, Inc. and Millennium Management LLC.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming KKR Real Estate Finance Trust Inc. and Terra REIT Advisors, LLC.
- Insider trades
652 insider-trade forms filed by directors and major holders
Shown as a count until Loro reads the transactions inside them: who bought or sold, how many shares, at what price. Most filings: Avalonbay Communities Inc (19), Accenture plc (17), Citizens Financial Group Inc/Ri (11), Westlake Corp (10), Mesa Laboratories Inc /CO/ (9), Plains GP Holdings LP (9).
SEC Form 4
Showing the 150 most material of 357.
Friday 14 August 2026
898 records- Stake 13G
New passive stake of 5% or more
Schedule 13G naming ADAR1 Capital Management, LLC and Boundless Bio, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Boyd Gaming Corp and Cohen & Steers, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming D. E. Shaw & Co, L.P. and Rising Dragon Acquisition Corp.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming ADAR1 Capital Management, LLC and Amanat Acquisition Corp.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming AEVEX Corp. and Fidelity National Financial, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Eloxx Pharmaceuticals, Inc. and Nantahala Capital Management, LLC.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Uranium Energy Corp and Van Eck Associates Corp.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Cohen & Steers, Inc. and Omega Healthcare Investors Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Azitra, Inc. and Nantahala Capital Management, LLC.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Arcline Double Eagle Master Fund-A LP and Arxis, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming LMR Partners LLP and RRE Ventures Acquisition Corp.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Maywood Acquisition Corp. 2 and Polar Asset Management Partners Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming AWM Investment Company, Inc. and Spruce Biosciences, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Braveheart Bio, Inc. and Frazier Life Sciences Public Fund, L.P.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming ADAR1 Capital Management, LLC and Cyclerion Therapeutics, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Greenvale Capital LLP and Sunrun Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Citadel Advisors LLC and Village Farms International, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Cue Biopharma, Inc. and Driehaus Capital Management LLC.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Citadel Securities GP LLC and Domo, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Aperture AC and Polar Asset Management Partners Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Boost Run Inc. and TOMS Capital Investment Management LP.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Citadel Advisors LLC and XCHG Ltd.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Femasys Inc and Rosalind Advisors, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Research Alliance Corp III and TCG Crossover GP III, LLC.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Graf Global Corp. and Polar Asset Management Partners Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Fulcrum Therapeutics, Inc. and Nantahala Capital Management, LLC.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Elevra Lithium Ltd and Van Eck Associates Corp.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Lakewood-Amedex Biotherapeutics Inc. and WFI Equity, LLC.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Cartesian Growth Corp IV and LMR Partners LLP.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming LMR Partners LLP and Spectral AI, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Caligan Partners LP and Cellectar Biosciences, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Long Focus Capital Management, LLC and Standard Biotools Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Karpus Management, Inc. and Morgan Stanley India Investment Fund, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Coatue Management LLC and Forgent Power Solutions, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming IsoEnergy Ltd. and Van Eck Associates Corp.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Ameriprise Financial Inc and Bellring Brands, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Harvard Ave Acquisition Corp and Polar Asset Management Partners Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Apogee Acquisition Corp and Polar Asset Management Partners Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Disciplined Growth Acquisition Corp and Polar Asset Management Partners Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Blaize Holdings, Inc. and Polar Asset Management Partners Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming HBK Investments L P and QXO Insulation, LLC.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming John Hancock Income Securities Trust and Karpus Management, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Berto Acquisition Corp. II and Berto Acquisition Sponsor II LLC.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Driehaus Capital Management LLC and Frequency Electronics Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming APEX Tech Acquisition Inc. and Karpus Management, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Man Alternative Income Fund and Man Investments Finance Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Cardinal Infrastructure Group Inc. and Driehaus Capital Management LLC.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Brown Advisory Inc and Lumexa Imaging Holdings, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Avoro Capital Advisors LLC and Hemab Therapeutics Holdings, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Collective Acquisition Corp. II and Polar Asset Management Partners Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Coatue Management LLC and Cerebras Systems Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Karpus Management, Inc. and Peace Acquisition Corp.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming CH4 Natural Solutions Acquisition Sponsor LLC and CH4 Natural Solutions Corp.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Graf Global Corp. and LMR Partners LLP.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming GSR V Acquisition Corp. and LMR Partners LLP.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming LendingTree, Inc. and Punch & Associates Investment Management, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Monte Rosa Therapeutics, Inc. and Vestal Point Capital, LP.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming LMR Partners LLP and Patriot Acquisition Corp./CI.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Senseonics Holdings, Inc. and Sessa Capital IM, L.P.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Trkla Thomas N. and Yesway, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming AWM Investment Company, Inc. and Liberty Defense Holdings, Ltd.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Fund 1 Investments, LLC and Genesco Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Aeon Acquisition I Corp. and Aeon Acquisition Partners I LLC.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Collective Acquisition Corp. II and LMR Partners LLP.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming LMR Partners LLP and Tribeca Strategic Acquisition Corp.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming LMR Partners LLP and NewHold Investment Corp IV.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Myriad Genetics Inc and Vestal Point Capital, LP.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Kodiak AI, Inc. and LMR Partners LLP.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Atrium Therapeutics, Inc. and Sessa Capital IM, L.P.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Destiny Tech100 Inc. and J. Goldman & Co LP.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming ACP Holdings Acquisition Corp. and Polar Asset Management Partners Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Breeze Acquisition Corp. II and Polar Asset Management Partners Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Bamco Inc /NY/ and On Holding AG.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Polar Asset Management Partners Inc. and QuasarEdge Acquisition Corp.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Bamco Inc /NY/ and Morningstar, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming AIRO Group Holdings, Inc. and Kathuria Chirinjeev.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming FutureCorp Space Acquisition 1 and Polar Asset Management Partners Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Elliott Investment Management L.P. and Pinterest, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming American Century Investment Management Inc and Harley-Davidson, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming American Century Investment Management Inc and Allegiant Travel CO.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Alyeska Investment Group, L.P. and New Horizon Aircraft Ltd.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Poet Technologies Inc. and Susquehanna Securities, LLC.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Armistice Capital, LLC and Rapid Micro Biosystems, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Alyeska Investment Group, L.P. and Factorial Energy Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Fulton Financial Corp and Price T Rowe Associates Inc /MD/.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Heico Corp and Price T Rowe Associates Inc /MD/.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Evommune, Inc. and Price T Rowe Associates Inc /MD/.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Fti Consulting, Inc and Price T Rowe Associates Inc /MD/.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming American Century Investment Management Inc and Interface Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Ghaffarian Kamal Seyed and X-Energy, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Price T Rowe Associates Inc /MD/ and SLM Corp.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Celldex Therapeutics, Inc. and Price T Rowe Associates Inc /MD/.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming American Century Investment Management Inc and Cabot Corp.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Ameriprise Financial Inc and Pinterest, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Alyeska Investment Group, L.P. and Quantum Corp /DE/.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming American Century Investment Management Inc and Benchmark Electronics Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Orbis Investment Management Ltd and Wise Group plc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Autoliv Inc and Skandinaviska Enskilda Banken AB (publ).
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Ancient Art, L.P. and Upwork, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Mannkind Corp and Rubric Capital Management LP.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Hivemind Capital Partners, LLC and Upexi, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Clear Street LLC and StoneBridge Acquisition II Corp.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Alyeska Investment Group, L.P. and Einride AB.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Price T Rowe Associates Inc /MD/ and Vornado Realty Trust.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Clear Street LLC and Canna-Global Acquisition Corp.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Ameriprise Financial Inc and Five9, Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Ameriprise Financial Inc and DMC Global Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Camping World Holdings, Inc. and Nantahala Capital Management, LLC.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming BiomX Inc. and Nantahala Capital Management, LLC.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Cohen & Steers, Inc. and Kilroy Realty Corp.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming BXP, Inc. and Cohen & Steers, Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Cohen & Steers, Inc. and Equity Lifestyle Properties Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Acadia Realty Trust and Cohen & Steers, Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Paradigm Biocapital Advisors LP and Viridian Therapeutics, Inc.\DE.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming CoreWeave, Inc. and Intrator Michael N.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Kodiak AI, Inc. and Soros Fund Management LLC.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Avalo Therapeutics, Inc. and RA Capital Management, L.P.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Assembly Biosciences, Inc. and Paradigm Biocapital Advisors LP.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Lakeshore Acquisition III Corp. and Westchester Capital Management, LLC.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Future Money Acquisition Corp and Linden Capital L.P.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Ceribell, Inc. and TPG GP A, LLC.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Cardiol Therapeutics Inc. and MMCAP International Inc. SPC.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Ameriprise Financial Inc and Match Group, Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Biocryst Pharmaceuticals Inc and RA Capital Management, L.P.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Cabaletta Bio, Inc. and T. Rowe Price Investment Management, Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Immunome Inc. and T. Rowe Price Investment Management, Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming LMR Partners LLP and Melar Acquisition Corp. I/Cayman.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming CoinFund Management LLC and Eightco Holdings Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Alliancebernstein L.P. and Celsius Holdings, Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Caligan Partners LP and Faeth Therapeutics, Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming ARKO Petroleum Corp. and Cohen & Steers, Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Maze Therapeutics, Inc. and Paradigm Biocapital Advisors LP.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Nantahala Capital Management, LLC and Rallybio Corp.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Edgewise Therapeutics, Inc. and Paradigm Biocapital Advisors LP.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming AWM Investment Company, Inc. and Owlet, Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming AWM Investment Company, Inc. and Everspin Technologies Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Nantahala Capital Management, LLC and Unicycive Therapeutics, Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Anteris Technologies Global Corp. and Nantahala Capital Management, LLC.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Aura Biosciences, Inc. and Frazier Life Sciences Public Fund, L.P.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Immunic, Inc. and Nantahala Capital Management, LLC.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Skeena Resources Ltd and Van Eck Associates Corp.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Ameriprise Financial Inc and Empire State Realty Trust, Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming 908 Devices Inc. and AWM Investment Company, Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Grace Therapeutics, Inc. and Nantahala Capital Management, LLC.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Biotricity Inc. and Ionic Ventures, LLC.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Pacific Investment Management Co LLC and Venture Global, Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Sprott Inc. and i-80 Gold Corp.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Divisadero Street Capital Management, LP and Rush Street Interactive, Inc.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Kynam Capital Management, LP and Viridian Therapeutics, Inc.\DE.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Cracker Barrel Old Country Store, Inc and GMT Capital Corp.
- Insider trades
506 insider-trade forms filed by directors and major holders
Shown as a count until Loro reads the transactions inside them: who bought or sold, how many shares, at what price. Most filings: Cinemark Holdings, Inc. (11), Hims & Hers Health, Inc. (10), Main Street Capital CORP (10), CoreWeave, Inc. (9), Caris Life Sciences, Inc. (8), Clene Inc. (8).
SEC Form 4
Showing the 150 most material of 392.
Thursday 13 August 2026
464 records- Insider trades
464 insider-trade forms filed by directors and major holders
Shown as a count until Loro reads the transactions inside them: who bought or sold, how many shares, at what price. Most filings: Consumer Portfolio Services, Inc. (14), First National Corp /VA/ (11), Applied Industrial Technologies Inc (8), Qorvo, Inc. (8), Fortinet, Inc. (7), Hadron Energy, Inc. (7).
SEC Form 4
Wednesday 12 August 2026
606 records- Insider trades
606 insider-trade forms filed by directors and major holders
Shown as a count until Loro reads the transactions inside them: who bought or sold, how many shares, at what price. Most filings: Katapult Holdings, Inc. (11), Icon PLC (9), Celestica Inc (8), Modiv Industrial, Inc. (8), STERIS plc (8), Appfolio Inc (7).
SEC Form 4
Tuesday 11 August 2026
639 records- Insider trades
639 insider-trade forms filed by directors and major holders
Shown as a count until Loro reads the transactions inside them: who bought or sold, how many shares, at what price. Most filings: Albertsons Companies, Inc. (17), Adi Global Distribution Inc. (13), Norwood Financial Corp (12), Lindblad Expeditions Holdings, Inc. (11), Snap Inc (11), Femasys Inc (10).
SEC Form 4
Monday 10 August 2026
517 records- Insider trades
517 insider-trade forms filed by directors and major holders
Shown as a count until Loro reads the transactions inside them: who bought or sold, how many shares, at what price. Most filings: Procter & Gamble Co (13), Taiwan Semiconductor Manufacturing Co Ltd (13), FS Bancorp, Inc. (11), Aptevo Therapeutics Inc. (10), BlossomHill Therapeutics, Inc. (9), Owens Corning (9).
SEC Form 4